Redmile Group, Director: Fate Therapeutics FATE Sell · Filed 24/12/26

Trade details

Type: Insider sale
Amount: $573,943.44
Shares · price: 341,633 sh · $1.68 a share
Held after: 12,486,313 sh
Stock: Fate Therapeutics FATE
Person: Redmile GroupDirector
Trade date: 24/12/20
Filed: 24/12/26
Days to filing: 6 days

Sold 2.7% of holdings

Share of holding sold: 2.7%

Fate Therapeutics trades, last 26 weeks

What else happened in Fate Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/20~25/01/19

Redmile Group's recent trades

Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$8.6M
2,634,506 sh
$8.6M
Filed 04/02
Traded 04/02
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$8.3M
2,529,491 sh
$8.3M
Filed 04/02
Traded 04/02
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$735.9K
196,229 sh
$735.9K
Filed 04/02
Traded 03/31
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$706.5K
188,407 sh
$706.5K
Filed 04/02
Traded 03/31
Redmile Group10% Owner
SellADC Therapeutics
Sell
ADC Therapeutics
ADCT
$643.2K
169,265 sh
$643.2K
Filed 04/02
Traded 04/01